Title for MeetingAbstracts
Alphabetical listing of titles
Model-based optimization of infectivity parameters.
Modeling AIDS awareness and behavior change among IDUs in Glasgow and New York.
Modeling and Interpreting Sampling Biased Vaccine Data.
Modeling anti-CD8 depletion and recovery of CD8+ T cells in SIV-infected macaques.
Modeling chronic disease progression and treatment cost-effectiveness.
Modeling communication networks and the spread of information on AIDS and people with AIDS in Uganda compared to other Sub-Saharan African contexts.
Modeling consequences of a prevention policy using multiple data sources and Bayesian bootstrap; example of the stroke prevention policy model.
Modeling costs and effectiveness of strategies for hearing screening shows benefits of universal neonatal screening.
Modeling effect of pharmacokinetics/adherence on protease inhibitors (pi) qd and bid regimens.
Modeling Efficient Mass Smallpox Vaccination Campaigns.
Modeling Exposure, Reliability and Recovery in Complex Clinical Settings.
MODELING HIV GENETIC VARIATION, EVOLUTION, AND RESISTANCE.
Modeling HIV pathogenesis using artificial life concepts and methods.
Modeling HIV reconstructions and projections: a sensitivity analysis.
Modeling HIV testing behavior and its impact on incidence estimation.
Modeling HIV Testing with the OraQuick Finger-Stick Test: More Effective and Less Costly than Oral Fluid Testing at Bathhouses and a Needle Exchange.
Modeling HIV transmission risk in non-intravenous drug injectors.
Modeling HIV/AIDS for public health decision making using only public health data.
Modeling HIV/AIDS trends in the U.S. by age, gender, race and exposure.
Modeling interventions to slow the spread of HIV.
Modeling of Host Transcription during Acute HIV Infection Using SHIV-infected Cynomolgus Macaques.
Modeling of New Drugs into the Ribosome.
Modeling of STDs and HIV: The value of STD surveillance and control in AIDS control programs.
Modeling of the change in CD4 cell counts in patients before and after receiving the HIV-protease inhibitor MK-639 (indinavir).
Modeling out-of-pocket expenses for Medicare risk enrollees.
Modeling Quality Improvement for Depression.
Modeling reimbursement cost of survival for very low birth weight infants (VLBWI) under a prospective payment system.
Modeling reliance on high-tech medicine among medical and nursing students.
Modeling risk of HIV transmission from Canadian surgeons to patients.
Modeling Risk-Adjusted Capitation Rates in Italy.